UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    Form 10-Q


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended: March 31, 2009

[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________

Commission file number 000-26703

                     MEDICAL MAKEOVER CORPORATION OF AMERICA
         ---------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


Delaware                            000-11596               65-0907798
----------------------------       ------------            -------------------
(State or other jurisdiction        (Commission            (IRS Employer
of incorporation)                   file number)           Identification No.)


                      2300 Palm Beach Lakes Blvd, Suite 218
                             West Palm Beach FL33409
           -----------------------------------------------------------
               (Address of principal executive offices)(Zip Code)


Registrant's telephone number, including area code: (561) 697-8740


                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changes since last report)









<PAGE>



Indicate by check mark whether the issuer (1) has filed all reports  required to
be filed by  Section  13 or 15(d) of the  Securities  Exchange  Act  during  the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days.       Yes |X| No |_|.



Indicate by check mark whether the registrant is an accelerated filer, a
non-accelerated filer, or a smaller reporting company.

     Large accelerated filer |_|           Accelerated filer          |_|
     Non-accelerated filer   |_|           Smaller reporting company  |X|



Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).        Yes |X| No |_|.



                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

As of May 11, 2009, there were approximately  112,261,858 shares of the Issuer's
common stock, par value $0.0001 per share outstanding.



              CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain  statements in this quarterly report on Form 10-Q contain or may contain
forward-looking  statements  that  are  subject  to  known  and  unknown  risks,
uncertainties  and other factors which may cause actual results,  performance or
achievements to be materially different from any future results,  performance or
achievements  expressed  or implied by such  forward-looking  statements.  These
forward-looking  statements  were  based on  various  factors  and were  derived
utilizing  numerous  assumptions  and other  factors that could cause our actual
results to differ materially from those in the forward-looking statements. These
factors  include,  but  are not  limited  to,  economic,  political  and  market
conditions and fluctuations,  government and industry regulation,  interest rate
risk, U.S. and global competition,  and other factors including the risk factors
set forth in our Form  10-KSB.  Most of these  factors are  difficult to predict
accurately and are generally  beyond our control.  You should consider the areas
of risk described in connection with any forward-looking  statements that may be
made  herein.  Readers  are  cautioned  not to  place  undue  reliance  on these
forward-looking  statements,  which  speak  only as of the date of this  report.
Readers should carefully review this quarterly report in its entirety, including
but not limited to our financial  statements and the notes  thereto.  Except for
our ongoing  obligations  to  disclose  material  information  under the Federal
securities laws, we undertake no obligation to release publicly any revisions to
any forward-looking  statements, to report events or to report the occurrence of
unanticipated  events.  For  any  forward-looking  statements  contained  in any
document,  we claim  the  protection  of the  safe  harbor  for  forward-looking
statements contained in the Private Securities Litigation Reform Act of 1995.




<PAGE>



                                     INDEX

PART I  - FINANCIAL INFORMATION

Item 1.  Financial Statements

Item 2   Management's Discussion and Analysis of Financial Condition and Results
         of Operations

Item 3   Quantitative and Qualitative Disclosures About Market Risk

Item 4T  Controls and Procedures

PART II  - OTHER INFORMATION

Item 1     Legal Proceedings

Item 1A    Risk Factors

Item 2     Unregistered Sales of Equity Securities and Use of Proceeds

Item 3     Defaults Upon Senior Securities

Item 4     Submission of Matters to a Vote of Security Holders

Item 5     Other Information

Item 6     Exhibits

SIGNATURES

EXHIBITS






<PAGE>


                         PART I - FINANCIAL INFORMATION

Item 1 Financial Statements

                          INDEX TO FINANCIAL STATEMENTS




Balance Sheet................................................................F-2

Statements of Operations.....................................................F-3

Statements of Stockholders' Equity...........................................F-4

Statements of Cash Flows.....................................................F-5

Notes to Financial Statement.................................................F-6























                                       F-1
<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                                  Balance Sheet


                                                                                  March 31,     December
                                                                                    2009        31, 2008
                                                                                ------------- ------------
                                                                                 (Unaudited)
<S>                                                                             <C>           <C>
                                     ASSETS
CURRENT ASSETS
  Cash                                                                          $           0 $          0
  Accounts receivable                                                                       0            0
                                                                                ------------- ------------

          Total current assets                                                              0            0
                                                                                ------------- ------------

OTHER ASSETS
   Other assets                                                                             0            0
                                                                                ------------- ------------

          Total other assets                                                                0            0
                                                                                ------------- ------------
Total Assets                                                                    $           0 $          0
                                                                                ============= ============

                      LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES

     Accounts payable                                                           $     237,597 $    237,597
     Stockholder loans and accrued interest                                            20,459       20,459
     Undocumented loan from third party                                                12,465            0
     Note payable                                                                     145,610      142,938
                                                                                ------------- ------------
          Total current liabilities                                                   416,131      400,994
                                                                                ------------- ------------

Total Liabilities                                                                     416,131      400,994
                                                                                ------------- ------------

STOCKHOLDERS' EQUITY
  Preferred stock, $0.0001 par value, 10,000,000 shares authorized,
       0 issued and outstanding                                                             0            0
  Common stock, $0.0001 par value, authorized 200,000,000 shares;
      112,261,858 issued and outstanding                                               11,226       11,226
  Additional paid-in capital                                                        1,053,370    1,053,370
  Deficit accumulated during the development stage                                 (1,480,727)  (1,465,590)
                                                                                ------------- ------------
          Total stockholders' equity                                                 (416,131)    (400,994)
                                                                                ------------- ------------
Total Liabilities and  Stockholders' Equity                                     $           0 $          0
                                                                                ============= ============
</TABLE>




     The accompanying notes are an integral part of the financial statements


                                       F-2
<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                            Statements of Operations
                          Three Months Ended March 31,
                                   (unaudited)


                                                                                                      From March
                                                                                                       29, 1999
                                                                                                    (Inception) to
                                                                                                      March 31,
                                                                  2009               2008                2009
                                                             ---------------    ---------------    ----------------

<S>                                                          <C>                <C>                <C>
REVENUES                                                     $             0    $             0    $         44,413
                                                             ---------------    ---------------    ----------------

OPERATING EXPENSES
   General and administrative                                            465             10,000           1,222,451
   Professional fees                                                  12,000              6,500             263,448
                                                             ---------------    ---------------    ----------------

          Net operating loss                                          12,465             16,500           1,485,899
                                                             ---------------    ---------------    ----------------

   Interest expense                                                    2,672              3,262              39,241
                                                             ---------------    ---------------    ----------------


Net loss                                                     $       (15,137)   $       (19,762)   $     (1,480,727)
                                                             ===============    ===============    ================

Basic net loss per share                                     $         (0.01)   $         (0.01)
                                                             ===============    ===============

Weighted average shares outstanding                              112,261,858         77,393,592
                                                             ===============    ===============
</TABLE>

















     The accompanying notes are an integral part of the financial statements


                                       F-3
<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                   Statement of Stockholders' Equity (Deficit)



                                                                                                   Deficit
                                                                                                Accumulated
                                                                                 Additional      During the         Total
                                                        Number of     Common       Paid-in      Development     Stockholders'
                                                         Shares        Stock       Capital         Stage           Equity
                                                      ------------- ----------- ------------- ---------------- ---------------
<S>                        <C>                           <C>        <C>         <C>           <C>              <C>

BEGINNING BALANCE, January 1, 2005                       46,996,913 $     4,700 $     463,168 $       (562,336)$       (94,468)

Shares issued for services                                4,595,505         459       257,203                0         257,662
Net loss                                                          0           0             0         (693,568)       (693,568)
                                                      ------------- ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2005                               51,592,418       5,159       720,371       (1,255,904)       (530,374)
Shares issued for services                                  300,000          30        16,470                0          16,500
Shares issued to settle debt and  interest expense       13,205,800       1,321       231,284                0         232,605
Net loss                                                          0           0             0          (69,104)        (69,104)
                                                      ------------- ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2006                               65,098,218       6,510       968,125       (1,325,008)       (350,373)
Shares issued to settle debt and  interest expense       12,294,411       1,229        31,581                0          32,810

Net loss                                                          0           0             0          (78,730)        (78,730)
                                                      ------------- ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2007                               77,392,629       7,739       999,706       (1,399,027)       (391,582)
Shares issued to settle debt and  interest expense       34,869,229       3,487        53,664                0          57,151
Net loss                                                          0           0             0          (66,563)        (66,563)
                                                      ------------- ----------- ------------- ---------------- ---------------
BALANCE, December 31, 2008                              112,261,858      11,226     1,053,370       (1,465,590)       (400,994)
Net loss                                                          0           0             0          (15,137)        (15,137)
                                                      ------------- ----------- ------------- ---------------- ---------------
ENDING BALANCE, March 31, 2009 (unaudited)              112,261,858 $    11,226 $   1,053,370 $     (1,480,727)$      (416,131)
                                                      ============= =========== ============= ================ ===============
</TABLE>
















     The accompanying notes are an integral part of the financial statements


                                       F-4
<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                            Statements of Cash Flows
                          Three Months Ended March 31,
                                   (Unaudited)


                                                                                                       From March
                                                                                                        29, 1999
                                                                                                     (Inception) to
                                                                    2009              2008           March 31, 2009
                                                             ------------------ -----------------   ----------------
<S>                                                                   <C>               <C>         <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                                              $(15,137)         $(19,762)   $     (1,480,727)
Adjustments to reconcile net loss to net cash used by
 operating activities:
    Stock issued for services                                                 0                 0            440,422
    Depreciation                                                              0                 0              3,445
Changes in operating assets and liabilities
    Increase (decrease) in accounts payable & acc'd expenses                  0            16,500            237,597
    Increase (decrease) in accrued interest expense                       2,672             3,262             29,780
                                                             ------------------ -----------------   ----------------
Net cash provided (used) by operating activities                        (12,465)                0           (769,483)
                                                             ------------------ -----------------   ----------------

CASH FLOWS FROM INVESTING ACTIVITIES:
 Purchase of fixed assets                                                     0                 0            (20,671)
                                                             ------------------ -----------------   ----------------
Net cash provided (used) by investing activities                              0                 0            (20,671)
                                                             ------------------ -----------------   ----------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock for cash                               0                 0            315,000
Proceeds from stockholder loan payable                                        0                 0             78,189
Payments on stockholder loans                                                 0                 0            (35,500)
Proceeds from third party notes payable                                  12,465                 0            432,465
                                                             ------------------ -----------------   ----------------
Net cash provided by financing activities                                12,465                 0            790,154
                                                             ------------------ -----------------   ----------------

Net increase (decrease) in cash                                               0                 0                  0
                                                             ------------------ -----------------   ----------------
CASH, beginning of period                                                     0                 0                  0
                                                             ------------------ -----------------   ----------------
CASH, end of period                                          $                0 $               0   $              0
                                                             ================== =================   ================
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION:
Non-Cash Financing Activities:
   Common stock issued for reduction in notes payable and
 accrued interest                                            $                0 $               0
                                                             ================== =================
</TABLE>








     The accompanying notes are an integral part of the financial statements


                                       F-5
<PAGE>



                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                          NOTES TO FINANCIAL STATEMENTS
                    (Information with regard to the 3 months
                   ended March 31, 2009 and 2008 is unaudited)


Note 1 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     (a) The  Company  Medical  Makeover  Corporation  of  America is a Delaware
     chartered  development  stage  corporation which conducts business from its
     headquarters in West Palm Beach, Florida. It was formed on March 29, 1999.

     The  following  summarize  the more  significant  accounting  and reporting
policies and practices of the Company:

     (b) Use of  estimates  The  financial  statements  have  been  prepared  in
     conformity with generally accepted accounting principles.  In preparing the
     financial  statements,   management  is  required  to  make  estimates  and
     assumptions  that affect the reported  amounts of assets and liabilities as
     of the date of the  statements  of  financial  condition  and  revenues and
     expenses for the year then ended.  Actual results may differ  significantly
     from those estimates.

     (c) Start-up  costs Costs of start-up  activities,  including  organization
     costs,  are expensed as incurred,  in accordance with Statement of Position
     (SOP) 98-5.

     (d) Stock  compensation for services  rendered The Company may issue shares
     of  common  stock in  exchange  for  services  rendered.  The  costs of the
     services are valued according to generally accepted  accounting  principles
     and have been charged to operations.

     (e) Net  income  (loss)  per  share  Basic  loss per share is  computed  by
     dividing  the net income  (loss) by the weighted  average  number of common
     shares outstanding during the period.

     (f) Property and  equipment All property and equipment are recorded at cost
     and depreciated over their estimated useful lives,  using the straight-line
     method.  Upon  sale  or  retirement,   the  cost  and  related  accumulated
     depreciation  are  eliminated  from  their  respective  accounts,  and  the
     resulting  gain or loss is included in the results of  operations.  Repairs
     and  maintenance  charges,  which do not  increase  the useful lives of the
     assets, are charged to operations as incurred.

     (g) Interim  financial  information The financial  statements for the three
     months  ended  March  31,  2009 and  2008 are  unaudited  and  include  all
     adjustments  which in the  opinion of  management  are  necessary  for fair
     presentation,  and such  adjustments are of a normal and recurring  nature.
     The results for the six months are not indicative of a full year results.


NOTE 2 - GOING CONCERN

The  accompanying  financial  statements  have been  prepared  assuming that the
Company will continue as a going concern.  The Company's  financial position and
operating  results  raise  substantial  doubt  about the  Company's  ability  to
continue  as a  going  concern,  as  reflected  by the net  loss  of  $1,480,727
accumulated  through March 31, 2009. The ability of the Company to continue as a
going concern is dependent  upon  commencing  operations,  developing  sales and
obtaining  additional  capital and  financing.  The financial  statements do not
include  any  adjustments  that might be  necessary  if the Company is unable to
continue as a going concern. The Company is currently seeking additional capital
to allow it to begin its planned operations




                                       F-6
<PAGE>


                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                          NOTES TO FINANCIAL STATEMENTS


NOTE 3 - NOTES PAYABLE

In December 2004, the Company received $20,000 and $115,000 in the first quarter
2005, in cash as a short-term  loan. This loan matures in six months and carries
a 8% interest  rate. In June 2005, the Company  received a $250,000  convertible
loan from a third party. This loan matures in six months and is in default,  and
carries a 8% interest rate.

In the first quarter 2009, the Company  borrowed  $12,465 from a third party, as
an advance to a line of credit to be determined.


NOTE 4 - CASH AND CASH EQUIVALENTS

For purposes of the  statement of cash flows,  the Company  considers all highly
liquid  investments  with maturity of three months or less when  purchased to be
cash equivalents


NOTE 5 - USE OF ESTIMATES

The  financial  statements  have been  prepared in  conformity  with  accounting
principles  generally  accepted in the United States. In preparing the financial
statements, management is required to make estimates and assumptions that affect
the reported  amounts of assets and liabilities as of the date of the statements
of financial condition and revenues and expenses for the year then ended. Actual
results may differ significantly from those estimates.












                                       F-7
<PAGE>



Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operations

     The following  discussion and analysis  should be read in conjunction  with
our Financial Statements and Notes thereto appearing elsewhere in this Report on
Form 10-Q as well as our other SEC filings.

Overview

     The Company is a  development  stage  company and has not yet  generated or
realized any revenues from business operations.  The Company's business strategy
changed in the third quarter 2007 to seeking  potential merger  candidates.  The
Company's  auditors have issued a going concern opinion in our audited financial
statements  for the fiscal year ended  December  31,  2008.  This means that our
auditors  believe  there is doubt that the Company  can  continue as an on-going
business for the next twelve months unless it obtains  additional capital to pay
its bills.  This is because the Company has not  generated  any  revenues and no
revenues are currently anticipated. Accordingly, we must raise cash from sources
such as investments by others in the Company and through  possible  transactions
with  strategic  or joint  venture  partners.  We do not plan to use any capital
raised  for the  purchase  or sale of any plant or  significant  equipment.  The
following  discussion  and  analysis  should  be read in  conjunction  with  the
financial  statements  of the  Company  and  the  accompanying  notes  appearing
subsequently under the caption "Financial Statements."

     Comparison of Operating Results for the Quarter Ended March 31, 2009 to the
Quarter Ended March 31, 2008

Revenues

     The Company did not  generate any revenues  from  operations  for the three
months ended March 31, 2009 or 2008. Accordingly, comparisons with prior periods
are  not   meaningful.   The  Company  is  subject  to  risks  inherent  in  the
establishment of a new business enterprise,  including limited capital resources
and cost increases in services.

Operating Expenses

     Operating expenses was declined $4,035 for the three months ended March 31,
2009 compared to the three months ended March 31, 2008, from $16,500 to $12,465.
This decline is a result of the change in management

Interest Expense

     Interest  expense  for the three  months  ended March 31, 2009 and 2008 was
$2,672 and $3,262, respectively.

Net Income/Loss

Net loss decreased by $4,625 from a net loss of $19,762 for the three months
ended March 31, 2008 to a net loss of $15,137 for the three months ended March
31, 2009. The decrease in net operating loss is due to decreased interest
expense and reduced operating expenses

     At March 31, 2009, our accumulated deficit was $1,480,727.



                                       11
<PAGE>


Assets and Liabilities

     Our total assets were $0 at March 31, 2009.

     Total Current Liabilities are $416,131 at March 31, 2009. Our notes payable
are $158,075.

Financial Condition, Liquidity and Capital Resources

     At March 31,  2009,  we had cash and cash  equivalents  of $0. Our  working
capital is presently  minimal and there can be no assurance  that our  financial
condition  will  improve.  To  date,  we  have  not  generated  cash  flow  from
operations.

     As of March 31, 2009,  we had a working  capital  deficit of $416,131.  The
Company will seek funds from possible  strategic and joint venture  partners and
financing to cover any short term  operating  deficits and provide for long term
working capital.  No assurances can be given that the Company will  successfully
engage  strategic  or joint  venture  partners or  otherwise  obtain  sufficient
financing through the sale of equity.

     No trends have been identified which would materially  increase or decrease
our results of operations or liquidity.

Plan of Operation

     The Company's  plan of operation  through  December 31, 2009 is to focus on
finding a suitable  merger  candidate or a viable  business plan. The Company is
seeking to raise capital to implement the Company's  business  strategy.  In the
event  additional  capital  is not  raised,  the  Company  may  seek  a  merger,
acquisition or outright sale.

Critical Accounting Policies

     Use of Estimates:  The  preparation  of financial  statements in conformity
with accounting  principles  generally  accepted in the United States of America
requires  management to make estimates and assumptions  that affect the reported
amounts  of assets and  liabilities  and  disclosure  of  contingent  assets and
liabilities at the date of the financial  statements and the reported amounts of
revenues and expenses during the reporting  period.  Actual results could differ
materially from those estimates.

     Loss per share:  Basic loss per share excludes  dilution and is computed by
dividing the loss  attributable to common  shareholders by the  weighted-average
number of common  shares  outstanding  for the  period.  Diluted  loss per share
reflects  the  potential  dilution  that  could  occur  if  securities  or other
contracts to issue common stock were exercised or converted into common stock or
resulted  in the  issuance of common  stock that  shared in the  earnings of the
Company.  Diluted loss per share is computed by dividing  the loss  available to
common  shareholders by the weighted average number of common shares outstanding
for  the  period  and  dilutive   potential  common  shares  outstanding  unless
consideration  of  such  dilutive   potential  common  shares  would  result  in
anti-dilution.  Common stock  equivalents were not considered in the calculation
of diluted loss per share as their effect would have been anti- dilutive for the
periods ended March 31, 2009 and 2008.



                                       12
<PAGE>



Going Concern.

     The Company has suffered recurring losses from operations and is in serious
need of  additional  financing.  These  factors  among others  indicate that the
Company may be unable to continue as a going concern,  particularly in the event
that it cannot  obtain  additional  financing or, in the  alternative,  affect a
merger or  acquisition.  The Company's  continuation  as a going concern depends
upon its ability to generate  sufficient cash flow to conduct its operations and
its  ability  to  obtain  additional  sources  of  capital  and  financing.  The
accompanying  financial  statements do not include any  adjustments  that may be
necessary if the Company is unable to continue as a going concern.


Item 3  Quantitative and Qualitative Disclosures About Market Risk

     The  Company is not  subject to any  specific  market  risk other than that
encountered by any other public company related to being publicly traded.


Item 4T Controls and Procedures

     Our management,  which includes our Chief Executive Officer who also serves
as  our  principal  financial  officer,  have  conducted  an  evaluation  of the
effectiveness  of our  disclosure  controls and  procedures  (as defined in Rule
13a-14(c) promulgated under the Securities and Exchange Act of 1934, as amended)
as of a date (the "Evaluation Date") as of the end of the period covered by this
report.  Based upon that evaluation,  during 2008, our management concluded that
our disclosure  controls and procedures were not effective for timely gathering,
analyzing  and  disclosing  the  information  we are required to disclose in our
reports filed under the Securities Exchange Act of 1934, as amended,  because of
adjustments required by our independent auditors, primarily in the area of notes
payable.  Specifically,  our independent auditors identified deficiencies in our
internal  controls and disclosures  related to the valuation and amortization of
beneficial  conversion features on our notes payable. We have made the necessary
adjustments to our financial  statements and footnote disclosures in our Interim
Report on Form 10-Q. We believe that our disclosure  controls and procedures are
now  effective  based upon the conduct of our  evaluation  for the period  ended
March 31, 2009.  We are  continually  in the process of  improving  our internal
controls in an effort to discover and remediate any deficiencies prior to filing
any report. There have been no significant changes made in our internal controls
or in other  factors  that  could  significantly  affect our  internal  controls
subsequent  to the end of the  period  covered  by  this  report  based  on such
evaluation.



                          PART II - OTHER INFORMATION

Item 1   Legal Proceedings

     The  Company  is a  defendant  in a civil  action  styled  Glen v.  Medical
Makeover  Corporation  of America,  et al, Case Number #  200594178H,  currently
pending in the  Circuit  Court of the Fifteen  Judicial  Circuit IN AND FOR Palm
Beach County,  Florida. The action was filed by a former employee of the company
asserting  claims against the Company  resulting  from his  discharge,  and also
includes  claims  that the  Company  took  certain  alleged  protected  business
concepts and practices  from him to and for the benefit of the Company,  for all
of which  he has  been  allegedly  damaged.  The  Company  and its  counsel  are
currently  defending this action and believe that the claims as made are without
merit and are defensible. The Company intends to vigorously defend these claims.



                                       13
<PAGE>


Item 2   Unregistered Sales of Equity Securities and Use of Proceeds

     None.


Item 3   Defaults Upon Senior Securities

     None


Item 4   Submission of Matters to a Vote of Security Holders

     None


Item 5   Other Information

     None


Item 6   Exhibits

     (a) The following  sets forth those  exhibits filed pursuant to Item 601 of
Regulation S-K:

Exhibit
number      Descriptions
--------  -----------------------
31.1   *  Certification  of the Chief  Executive  Officer,  dated May 15,  2009,
          pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

31.2   *  Certification  of the Acting Chief  Financial  Officer,  dated May 15,
          2009, pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

32.1   *  Certification of Chief Executive Officer, dated May 15, 2009, pursuant
          to Section 906 of Sarbanes-Oxley Act of 2002.

32.1   *  Certification  Acting  Chief  Financial  Officer,  dated May 15, 2009,
          pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
------------
*    Filed herewith.

     (b) The following  sets forth the  Company's  reports on Form 8-K that have
been filed during the quarter for which this report is filed:

     None.



                                    SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.


                     Medical Makeover Corporation of America

                                   By:      /s/ Jason Smart
                                           ---------------------------
                                           Jason Smart
                                           Chief Executive Officer,
                                           President and Chairman of the Board*
Date: May 15, 2009

*    Jason  Smart  has  signed  both  on  behalf  of  the  registrant  as a duly
     authorized officer and as the Registrant's principal accounting officer.



                                       14